BusinessNewsHealth
0
First-of-its-kind annual HIV shot moves closer to reality, passes key trial - Interesting Engineering
A new annual HIV injection, lenacapavir, shows promising early trial results, potentially offering a long-lasting alternative to daily PrEP pills.
Comments